CellChorus wins the 2023 Houston Life Sciences Business of the year

Award recognizes use of AI to evaluate immune cell function and performance to improve the development and delivery of therapeutics

PRESS RELEASE

HOUSTON, Texas — November 10, 2023 — CellChorus Inc., the leader in applying artificial intelligence to visually evaluate how thousands of individual cells perform over time, has been awarded the Life Sciences Business of the year at the Houston Innovation Awards Gala. The awards were hosted by Houston Exponential and InnovationMap at the Sawyer Yards Silver Street Studios.

Learn more about the winners from all categories here:

About CellChorus

CellChorus is the leader in applying artificial intelligence (AI) to visually evaluate how thousands of individual immune cells, such as T cells and NK cells, perform over time. The company applies Time lapse Imaging Microscopy in Nanowell Grids™ (TIMING™) with neural network-based AI to identify cells and evaluate their activity, including how they move, activate, kill and survive. The patent-protected CellChorus platform can link TIMING data and insights with information from other analysis modalities such as single-cell RNA sequencing and flow cytometry to provide a comprehensive understanding of cellular function, state and phenotype for the life sciences industry. Please visit cellchorus.com for more information.

Company Contact:
Daniel Meyer
Chief Executive Officer
CellChorus Inc.
TIMING@cellchorus.com

SOURCE CellChorus Inc.